Immediate Impact
2 from Science/Nature 25 standout
Citing Papers
Transient loss of Polycomb components induces an epigenetic cancer fate
2024 StandoutNature
Electrochemical Biosensors for Whole Blood Analysis: Recent Progress, Challenges, and Future Perspectives
2023 Standout
Works of Mats Hardling being referenced
Not all imatinib resistance in CML are BCR-ABL kinase domain mutations
2006
Serial Monitoring of <I>BCR-ABL</I> Transcripts in Chronic Myelogenous Leukemia (CML) Treated with Imatinib Mesylate
2004
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Mats Hardling | 40 | 21 | 18 | 19 | 6 | 69 | |
| Maxi Wass | 29 | 22 | 9 | 15 | 7 | 70 | |
| A. R. Macgregor | 47 | 10 | 8 | 12 | 7 | 166 | |
| Federica Portale | 21 | 40 | 34 | 47 | 7 | 168 | |
| S. M. Wood | 54 | 10 | 71 | 18 | 5 | 164 | |
| Wilma Deplano | 53 | 18 | 18 | 16 | 5 | 75 | |
| Anitria Cotton | 28 | 13 | 25 | 21 | 6 | 61 | |
| Pietro Fabris | 51 | 13 | 17 | 7 | 6 | 64 | |
| Betsy Valles | 19 | 23 | 5 | 10 | 5 | 74 | |
| Aron Skaftason | 50 | 9 | 9 | 42 | 7 | 80 | |
| Anne Sophie Carret | 34 | 15 | 26 | 13 | 6 | 72 |
All Works
Loading papers...